Three acquirers are making an open offer for 26% of Rekvina Laboratories at ₹10 per share, totaling ₹2.89 crore.
The offer is triggered by a share swap for Radiant Parenterals and is made under SEBI's takeover regulations.
The open offer period runs from May 14 to May 27, 2026, with the acquirers seeking to increase their stake.